Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis
Stopped early
Conditions studied: Ovarian Cancer
In brief
The primary objective is to administer a cross-sectional survey to directly compare the differences patients and physicians hold regarding ovarian cancer prognosis and survival, complications arising from treatment, and counseling on advance directives, living wills, palliative care, and hospice services. Overall, the project will pinpoint opportunities for better patient physician communication regarding prognosis and end-of-life care and allow for more informed and tailored decision-making.
Key facts
- Study ID
- NCT02769546
- Run by
- Abramson Cancer Center at Penn Medicine
- People needed
- 50
- Starts
- 2016-01-01
- Expected to finish
- 2018-01-01
- Last updated by the study team
- 2020-04-02
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- women over 18 years old with biopsy-confirmed malignancy
- being actively treated or are in surveillance for epithelial ovarian cancer
- have an existing therapeutic relationship with a provider who is participating in the study.
You may not qualify if…
- patients enrolled in palliative or hospice care programs, patients with a second primary malignancy within the last five years (excluding non-melanoma skin cancer)
- patients who are illiterate or non-English speaking, and patients without decision-making capacity.
- There are no exclusion criteria based on age, gender, economic status or race/ethnicity
Where it is running
- Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.